New Two-Dose Vaccine 100 Percent Effective Against Severe COVID

Published on February 23, 2022

French drugmaker Sanofi and its British partner GlaxoSmithKline are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as a standalone two-dose shot, after several setbacks. The companies said on Wednesday they intended to submit data to…

Read Full Article (External Site)